Julie Feder

Track

Insider profile

Currently holds a position at Aura Biosciences Inc

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Aura Biosciences Inc None -
Chief Financial Officer Verastem Inc July 10, 2017 - May 30, 2018
Julie Feder's trades of Aura Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-29 2024-10-29
PrS Proposed sale
5,565
55.23
US$2,139,708 		5,565 55.23 US$2,139,708
2024-10-21 2024-10-18
PlS Planned sale
1,873 +38.1%
292.31
US$1,847,934 		1,873 +38.1% 292.31 US$1,847,934
2024-10-18 2024-10-18
PrS Proposed sale
67,971
43.57
US$2,277,484 		67,971 43.57 US$2,277,484
2024-01-24 2024-01-23
PrS Proposed sale
6,609
7.64
US$50,521 		6,609 7.64 US$50,521
2024-01-24 2024-01-23
S Sale
6,609 -9.5%
7.64
US$50,521 		6,609 -9.5% 7.64 US$50,521
2023-11-07 2023-11-06
PlS Planned sale
3,900 -5.3%
12.07
US$47,054 		3,900 -5.3% 12.07 US$47,054
2023-11-06 2023-11-06
PrS Proposed sale
17,500
11.98
US$209,650 		17,500 11.98 US$209,650
2023-11-03 2023-10-30
PrS Proposed sale
3,385
6.82
US$23,091 		3,385 6.82 US$23,091
2023-11-01 2023-10-30
S Sale
3,385 -4.6%
6.82
US$23,091 		3,385 -4.6% 6.82 US$23,091
2022-11-02 2022-10-31
PlS Planned sale
2,015 -7.7%
12.45
US$25,090 		2,015 -7.7% 12.45 US$25,090